iAPADC-CTL治疗56例肝癌患者的护理  

Nursing of 56 liver cancer patients with iAPA DC-CTL therapy

作　　者：王彩会[1] 齐红云[1] 梁小莉[1] 张小凤[1] 

机构地区：[1]首都医科大学附属北京佑安医院介入一科,100069

出　　处：《中华现代护理杂志》2016年第22期3218-3220,共3页Chinese Journal of Modern Nursing

摘　　要：目的：总结56例肝癌患者行iAPA DC-CTL治疗的治疗情况及护理要点。方法根据北京佑安医院56例采用静脉回输iAPA DC-CTL免疫细胞治疗技术的治疗记录，总结其伴随反应，从回输前、采血、回输时和回输后四方面详细地阐述了护理情况和注意事项。结果56例患者均按时完成治疗，无一例出现严重不良反应。结论加强原发性肝癌患者行iAPA DC-CTL治疗的护理，可改善患者的生活质量，增强其免疫功能，且不良反应少。Objective To summarize the treatment status and key nursing point of 56 liver cancer patients with iAPA DC-CTL.Methods According to the treatment document of 56 cases using vein transfused iAPA DC-CTL immune cell therapy, we summarized the reaction and explained nursing status and matters needed attention before transfusion, blood taking, transfusion and after transfusion. Results All 56 patients completed the therapy and no one found out the adverse effects.Conclusions To strengthen the nursing of iAPA DC-CLT treatment in primary liver cancer patients can improve patients quality of life and immune function, and reduce adverse effects.

关 键 词：肝肿瘤 肿瘤细胞免疫治疗 

分 类 号：R473.73[医药卫生—护理学]